Endo International plc (NASDAQ:ENDP) finished Wednesday with a subtraction of -$0.05 to close at $4.12, a downside of -1.20 percent. An average of 6,738,060 shares of common stock have been traded in the last five days. There was a gain of $0.73 in the past week. The last 20 days have seen an average of 7,970,610 shares traded, while the 50-day average volume stands at 12,144,727.
ENDP stock has increased by 54.89% in the last month. The company shares reached their 1-month lowest point of $2.56 on 09/14/21. With the stock rallying to its 52-week high on 02/18/21, shares of the company touched a low of $1.94 and a high of $10.89 in 52 weeks. In spite of this, the price is down -62.17% from the 52-week high.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
213 days have passed since Endo International plc (ENDP) last reported insider trading activity. MONTAGUE WILLIAM P, who is Director, most recently acquired $9,033 shares at $8.68 per share on Mar 15. In this transaction, the insider spent $78,406. Director, Cooke Shane, disposed of 17,290 shares at a price of $8.65 on Mar 15. The insider now owns more than $149,558 worth of shares.
Endo International plc (ENDP) has a trailing price-to-earnings (P/E) ratio of 23.00 for the broader industry and 32.30 for the sector. In the last five years, Endo International plc’s PE ratio has ranged between 18.54 and 7.50. The stock’s beta is 1.10. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.30, and the price-to-cash flow ratio at 2.43.
The quick ratio of Endo International plc for the three months ended June 29 was 1.60, and the current ratio was 1.80, indicating that the company is able to meet its debt obligations. On the profitability front, the trailing 12-month gross margin is 54.90% against a 5-year average of 42.2%. Endo International plc’s EBITDA margin for the year ending June 29 is 38.65%, while its operating margin for the same period stands at 18.50%. Its gross profit as reported stood at $1.46 billion compared to revenue of $2.9 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Endo International plc’s return on assets was 0.80%, compared to -9.5% over the last five years.
The analyst consensus anticipated Endo International plc’s latest quarter earnings to come in at $0.48 per share, but it turned out to be $0.65, a 35.40% surprise. For the quarter, EBITDA amounted to $265.63 million. Shareholders own equity worth $233.5 million.
From a technical analysis perspective, let’s take a brief look at Endo International plc (ENDP) price momentum. RSI 9-day as of the close on 13 October was 74.88%, suggesting the stock is Overbought, with historical volatility in this time frame at 64.52%.
As of today, ENDP’s price is $4.04 +21.53% or $0.73 from its 5-day moving average. ENDP is currently trading +45.58% higher than its 20-day SMA and -26.30% lower than its 100-day SMA. However, the stock’s current price level is -10.63% below the SMA50 and -35.02% below the SMA200.
The stochastic %K and %D were 89.83% and 92.46%, respectively, and the average true range (ATR) was 0.29. With the 14-day stochastic at 84.75% and the average true range at 0.30, the RSI (14) stands at 68.59%. The stock has reached 0.39 on the 9-day MACD Oscillator while the 14-day reading was at 0.55.
Piper Sandler downgraded Endo International plc (NASDAQ: ENDP) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a an Overweight.The consensus rating for Endo International plc (ENDP) among analysts is Hold. According to current brokerage recommendations, 2 brokerage firms advise that investors sell ENDP, while 6 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is ENDP’s price target for the next 12 months?
Analysts predict a range of price targets between $3.00 and $11.00, with a median target of $7.00. Taking a look at these predictions, the average price target given by analysts for Endo International plc (ENDP) stock is $6.57.